Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gabriele Grassi is active.

Publication


Featured researches published by Gabriele Grassi.


Journal of Hepatology | 1995

Quantitative analysis of hepatitis C virus RNA in liver biopsies by competitive reverse transcription and polymerase chain reaction.

Gabriele Grassi; Gabriele Pozzato; M. Moretti; Mauro Giacca

BACKGROUND/AIMS The determination of HCV-RNA concentration in liver samples is likely to provide interesting insights for the study of disease progression and for evaluation of the efficacy of anti-viral therapy. METHODS A procedure was developed for the precise quantification of HCV-RNA in liver biopsies, based on the competitive reverse transcription-polymerase chain reaction technology. This competitive assay consists of the co-amplification of the target RNA with known amounts of a competitor RNA molecule containing the same sequence as the target plus an insertion in the middle, allowing resolution of the two amplification products by gel electrophoresis. RESULTS The amounts of HCV-genomic-RNA and beta-actin mRNA (the latter being used as an internal standard to overcome the problem of reproducibility of quantitative RNA extraction) were evaluated in liver biopsies of 15 patients affected by hepatitis C virus-positive chronic liver disease at the time of diagnosis. All the patients underwent alpha-interferon therapy for 6 months and were subsequently followed for at least 1 further year after the end of treatment. Viral RNA concentration (which ranged from 2 to 2.7 x 10(5) HCV-RNA molecules per 10(6) beta-actin molecules) directly correlated with the efficacy of treatment, indicating that low levels of viral replication in the liver are associated with a poor response to therapy. CONCLUSIONS This study suggests that the determination of viral load in the liver is an important prognostic tool for the prediction of the efficacy of alpha-interferon therapy.


Pediatric Research | 1997

DEVELOPMENT OF RIBOZYMES AS THERAPEUTIC AGENTS FOR DOMINANT GENETIC DISEASE: Allele-Specific Cleavage of Collagen Transcripts Shows Competitive Binding Effects. 616

Joan C. Marini; Gabriele Grassi; Antonella Forlino

DEVELOPMENT OF RIBOZYMES AS THERAPEUTIC AGENTS FOR DOMINANT GENETIC DISEASE: Allele-Specific Cleavage of Collagen Transcripts Shows Competitive Binding Effects. 616


Nucleic Acids Research | 1997

Cleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects.

Gabriele Grassi; Antonella Forlino; Joan C. Marini


Hepatology | 1998

Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease

Sabrina Brambilla; Giorgio Bellati; Margherita Asti; Antonella Lisa; Maria Elena Candusso; Maria D'Amico; Gabriele Grassi; Mauro Giacca; Angelo Franchini; Savino Bruno; G. Ideo; Mario U. Mondelli; Enrico Maria Silini


Nucleic Acids Research | 1994

A rapid procedure for the quantitation of low abundance RNAs by competitive reverse transcription-polymerase chain reaction.

Gabriele Grassi; Lorena Zentilin; Sabrina Tafuro; Silvia Diviacco; Alessandro Ventura; Arturo Falaschi; Mauro Giacca


Italian Journal of Gastroenterology and Hepatology | 1997

Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferon.

L. Mazzoran; Gabriele Grassi; Mauro Giacca; U. Gerini; S. Baracetti; Fanni-Canelles M; Francesca Zorat; Gabriele Pozzato


Experimental Cell Research | 1996

Functional reconstitution of oxidase activity in X-linked chronic granulomatous disease by retrovirus-mediated gene transfer.

Lorena Zentilin; Sabrina Tafuro; Gabriele Grassi; Rodolfo Garcia; Alessandro Ventura; Francisco E. Baralle; Arturo Falaschi; Mauro Giacca


Archive | 2015

Hydrogels mesh size evaluation

Mario Grassi; Simona Maria Fiorentino; Rossella Farra; Barbara Dapas; Gabriele Grassi


Archive | 2018

Drug delivery from polymeric matrices

Gianluca Chiarappa; Michela Abrami; Rossella Farra; Barbara Dapas; Gabriele Grassi; Mario Grassi


Journal of Cystic Fibrosis | 2018

WS06.3 A novel approach based on low field nuclear magnetic resonance to monitor lung functionality and inflammation in cystic fibrosis patients

Michela Abrami; Massimo Maschio; Massimo Conese; Marco Confalonieri; S. Di Gioia; Barbara Dapas; F. Tonon; R. Farra; Mario Grassi; Gabriele Grassi; F. Gerin

Collaboration


Dive into the Gabriele Grassi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mauro Giacca

International Centre for Genetic Engineering and Biotechnology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge